col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


75 Results       Page 1

 [1] 
American Association for Cancer Research: Clinical Cancer Research
  original article Date Title Authors   All Authors
1 [GO] 2022―Feb―09 AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta
2 [GO] 2021―Sep―28 Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, et al. (+18)
3 [GO] 2021―Jun―09 A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes David A. Potter, Alexandra Thomas, Hope S. Rugo
4 [GO] 2021―Mar―12 Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay
5 [GO] 2021―Mar―12 Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha
6 [GO] 2021―Mar―12 Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 Giulia Monticone, Alistair Ramsay, Lucio Miele
7 [GO] 2021―Mar―12 Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, et al. (+3)
8 [GO] 2021―Mar―12 Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler
9 [GO] 2021―Mar―12 Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew
10 [GO] 2021―Mar―12 Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay
11 [GO] 2021―Mar―12 Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19)
12 [GO] 2021―Mar―12 Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly
13 [GO] 2021―Mar―12 Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+24)
14 [GO] 2021―Mar―12 Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, et al. (+2)
15 [GO] 2021―Mar―12 Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh
16 [GO] 2021―Mar―12 Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, et al. (+9)
17 [GO] 2021―Mar―12 Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, et al. (+3)
18 [GO] 2021―Mar―12 Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, et al. (+35)
19 [GO] 2021―Mar―12 Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, et al. (+16)
20 [GO] 2021―Mar―12 Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses Richard Momparler
21 [GO] 2021―Mar―12 Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare
22 [GO] 2021―Mar―12 Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, et al. (+2)
23 [GO] 2021―Mar―12 Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard
24 [GO] 2021―Mar―12 Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi
25 [GO] 2021―Mar―12 Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, et al. (+20)
26 [GO] 2021―Mar―12 Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, et al. (+14)
27 [GO] 2021―Mar―12 Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom Menna M. Fouda, Ankit Jain
28 [GO] 2021―Mar―12 Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection Jian He, Mei Meng, Yiyang Zhao
29 [GO] 2021―Mar―12 Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, et al. (+14)
30 [GO] 2021―Mar―12 Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, et al. (+9)
31 [GO] 2021―Mar―12 Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita
32 [GO] 2021―Mar―12 Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh
33 [GO] 2021―Mar―12 Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, et al. (+22)
34 [GO] 2021―Mar―12 Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, et al. (+9)
35 [GO] 2021―Mar―12 Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni
36 [GO] 2021―Mar―12 Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, et al. (+5)
37 [GO] 2021―Mar―12 Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot
38 [GO] 2021―Mar―12 Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic Md Mohiuddin, Kazuo Kasahara
39 [GO] 2021―Mar―12 Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, et al. (+2)
40 [GO] 2021―Mar―12 Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis
41 [GO] 2021―Mar―12 Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, et al. (+5)
42 [GO] 2021―Mar―12 Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion Mary N. O'Reilly, Mark Doherty
43 [GO] 2021―Mar―12 Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, et al. (+6)
44 [GO] 2021―Mar―12 Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, et al. (+4)
45 [GO] 2021―Mar―12 Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, et al. (+12)
46 [GO] 2021―Mar―12 Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, et al. (+4)
47 [GO] 2021―Mar―12 Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji
48 [GO] 2021―Mar―12 Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, et al. (+22)
49 [GO] 2021―Mar―12 Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3)
50 [GO] 2021―Mar―12 Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera
51 [GO] 2021―Mar―12 Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan
52 [GO] 2021―Mar―12 Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, et al. (+8)
53 [GO] 2021―Mar―12 Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, et al. (+15)
54 [GO] 2021―Mar―12 Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, et al. (+2)
55 [GO] 2021―Mar―12 Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler
56 [GO] 2021―Mar―12 Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, et al. (+5)
57 [GO] 2021―Mar―12 Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, et al. (+15)
58 [GO] 2021―Mar―12 Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park
59 [GO] 2021―Mar―12 Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures Arutha Kulasinghe
60 [GO] 2021―Mar―12 Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, et al. (+4)
61 [GO] 2021―Mar―12 Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, et al. (+9)
62 [GO] 2021―Mar―12 Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, et al. (+25)
63 [GO] 2021―Mar―12 Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
64 [GO] 2021―Mar―12 Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, et al. (+6)
65 [GO] 2021―Mar―12 Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, et al. (+6)
66 [GO] 2021―Mar―12 Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, et al. (+8)
67 [GO] 2021―Mar―12 Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo
68 [GO] 2021―Mar―01 Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain
69 [GO] 2021―Feb―04 How did we get a COVID-19 vaccine in less than one year? E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas
70 [GO] 2020―Oct―13 Similarities in Risk for COVID-19 and Cancer Disparities Lisa Newman, Robert A Winn, John M. Carethers
71 [GO] 2020―Aug―18 The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3)
72 [GO] 2020―Jul―02 COVID-19 testing in cancer patients: Does one size fit all? Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3)
73 [GO] 2020―Jun―15 Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6)
74 [GO] 2020―Jun―05 The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. Fatima Karzai, Ravi A. Madan, William Dahut
75 [GO] 2020―Apr―20 Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic Aaron C Tan, David M Ashley, Mustafa Khasraw
 [1] 

75 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.015 sec